These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16964711)

  • 1. Preparation and targeted delivery of immunoliposomes bearing poly(ethylene glycol)-coupled humanized anti-hepatoma disulfide-stabilized Fv (hdsFv25) in vitro.
    Hu H; Chen D; Liu Y; Deng Y; Yang S; Qiao M; Zhao J; Zhao X
    Pharmazie; 2006 Aug; 61(8):685-8. PubMed ID: 16964711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation and in vitro tumor cells selectivity of sterically stabilized immunoliposomal peptides in bee venom].
    Hu HY; Chen DW; Liu YF; Qiao MX; Zhao XL
    Yao Xue Xue Bao; 2007 Nov; 42(11):1201-5. PubMed ID: 18300479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target ability and therapy efficacy of immunoliposomes using a humanized antihepatoma disulfide-stabilized Fv fragment on tumor cells.
    Hu H; Chen D; Liu Y; Deng Y; Yang S; Qiao M; Zhao J; Zhao X
    J Pharm Sci; 2006 Jan; 95(1):192-9. PubMed ID: 16315243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells.
    Gupta Y; Jain A; Jain P; Jain SK
    J Drug Target; 2007 Apr; 15(3):231-40. PubMed ID: 17454361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice in-vivo.
    Hu H; Chen D; Li Y; Zhang X
    J Pharm Pharmacol; 2006 Jan; 58(1):83-9. PubMed ID: 16393467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome.
    Yang T; Choi MK; Cui FD; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2007 Jul; 120(3):169-77. PubMed ID: 17586082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
    Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
    Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
    Pan H; Niu GQ; Pan J; Lu WY
    Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
    Pan X; Lee RJ
    Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
    Gao D; Tang S; Tong Q
    Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.
    Bestman-Smith J; Gourde P; Désormeaux A; Tremblay MJ; Bergeron MG
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):161-74. PubMed ID: 11018661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA; Polo D; Reig F; Fabra A
    J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.
    Kuai R; Yuan W; Li W; Qin Y; Tang J; Yuan M; Fu L; Ran R; Zhang Z; He Q
    Mol Pharm; 2011 Dec; 8(6):2151-61. PubMed ID: 21981683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.